Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...

Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in those with ulcerative colitis ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first ... and Takeda Pharma’s α4β7 inhibitor Entyvio (vedolizumab), both of which are ...

known as Entyvio SC, Spherix captured the initial impact of the launch on the EU5 Crohn’s disease (CD) and ulcerative colitis (UC) markets through their RealTime DynamixTM services. The latest ...

Living with IBD and having symptoms of Inflammatory Bowel ... They're having trouble to even wanting to engage with treatment providers or they may want to withdraw from treatment even.

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...